Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases

Microbiology and Immunology

Volumn 49, Issue 1, 2005, Pages 57-65

  Karasawa, Rie ^a   Ozaki, Shoichi ^a   Nishioka, Kusuki ^a   Kato, Tomohiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibody; Oxidative stress; Peroxiredoxin

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; NEUTROPHIL CYTOPLASMIC ANTIBODY; PEROXIREDOXIN; PEROXIREDOXIN I ANTIBODY; PEROXIREDOXIN IV ANTIBODY; UNCLASSIFIED DRUG;

ANAPHYLACTOID PURPURA; ANTIBODY DETECTION; AORTA ARCH SYNDROME; ARTICLE; CHURG STRAUSS SYNDROME; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GIANT CELL ARTERITIS; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MICROSCOPIC POLYANGIITIS; OXIDATIVE STRESS; POLYARTERITIS NODOSA; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; WEGENER GRANULOMATOSIS; WESTERN BLOTTING;

PURPURA;

EID: 14644439243     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2005.tb03640.x     Document Type: Article

References (43)

1. Amara, A., Constans, J., Chaugier, C., Sebban, A., Dubourg, L., Peuchant, E., Pellegrin, J.L., Leng, B., Conn, C., and Geffard, M. 1995. Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides. Clin. Exp. Immunol. 101: 233-238.
2. Ames, P.R., Alves, J., Murat, I., Isenberg, D.A., and Nourooz-Zadeh, J. 1999. Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement. Rheumatology (Oxford) 38: 529-534.
3. Arend, W.P., Michel, B.A., Bloch, D.A., Hunder, G.G., Calabrese, L.H., Edworthy, S.M., Fauci, A.S., Leavitt, R.Y., Lie, J.T., Lightfoot, R.W., Jr., et al. 1990. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 33: 1129-1134.
4. Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., Healey, L.A., Kaplan, S.R., Liang, M.H., Luthra, U.S., et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
5. Ashok, B.T., and Ali, R. 1998. Binding of human anti-DNA autoantibodies to reactive oxygen species modified-DNA and probing oxidative DNA damage in cancer using monoclonal antibody. Int. J. Cancer 78: 404-409.
6. Ashok, B.T., and Ali, R. 1998. Binding of circulating antibodies to reactive oxygen species modified-DNA and detecting DNA damage by a monoclonal antibody probe. Mech. Ageing Dev. 103: 69-80.
7. Bryk, R., Griffin, P., and Nathan, C. 2000. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407: 211-215.
8. Buerke, M., Prufer, D., Dahm, M., Oelert, H., Meyer, J., and Darius, H. 1998. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J. Pharmacol. Exp. Ther. 286: 429-438.
9. Chae, H.Z., Chung, S.J., and Rhee, S.G. 1994. Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 269: 27670-27678.
10. Chae, H.Z., Kang, S.W., and Rhee, S.G. 1999. Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin. Methods Enzymol. 300: 219-226.
11. Chae, H.Z., Robison, K., Poole, L.B., Church, G., Storz, G., and Rhee, S.G. 1994. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc. Natl. Acad. Sci. U.S.A. 91: 7017-7021.
12. Collard, C.D., Montalto, M.C., Reenstra, W.R., Buras, J.A., and Stahl, G.L. 2001. Endothelial oxidative stress activates the lectin complement pathway, role of cytokeratin 1. Am. J. Pathol. 159: 1045-1054.
13. Collard, C.D., Vakeva, A., Morrissey, M.A., Agah, A., Rollins, S.A., Reenstra, W.R., Buras, J.A., Meri, S., and Stahl, G.L. 2000. Complement activation after oxidative stress: role of the lectin complement pathway. Am. J. Pathol. 156: 1549-1556.
14. Csernok, E. 2003. Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmun. Rev. 2: 158-164.
15. Dalpke, A.H., Thomssen, R., and Ritter, K. 2003. Oxidative injury to endothelial cells due to Epstein-Barr virus-induced autoantibodies against manganese superoxide dismutase. J. Med. Virol. 71: 408-416.
16. Hofmann, B., Hecht, H.J., and Flohe, L. 2002. Peroxiredoxins. Biol. Chem. 383: 347-364.
17. Hunder, G.G., Bloch, D.A., Michel, B.A., Stevens, M.B., Arend, W.P., Calabrese, L.H., Edworthy, S.M., Fauci, A.S., Leavitt, R.Y., Lie, J.T., et al. 1990. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 33: 1122-1128.
18. Huugen, D., Tervaert, J.W., and Heeringa, P. 2004. Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models. Curr. Opin. Rheumatol. 16: 4-8.
19. International Study Group for Behçet's Disease. 1990. Criteria for diagnosis of Behçet's disease. Lancet 335: 1078-1080.
20. Iwaki-Egawa, S., Matsuno, H., Yudoh, K., Nakazawa, F., Miyazaki, K., Ochiai, A., Hirohata, S., Shimizu, M., and Watanabe, Y. 2004. High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen. J. Rheumatol. 31: 17-22.
21. Jennette, J.C., Falk, R.J., Andrassy, K., Bacon, P.A., Churg, J., Gross, W.L., Hagen, E.G., Hoffman, O.S., Hunder, G.G., Kallenberg, C.G., et al. 1994. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 37: 187-192.
22. Jin, D.Y., Chae, H.Z., Rhee, S.G., and Jeang, K.T. 1997. Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J. Biol. Chem. 272: 30952-30961.
23. Kallenberg, C.G., Rarok, A., Stegeman, C.A., and Limburg, PC. 2002. New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis. Autoimmun. Rev. 1: 61-66.
24. Kilgore, K.S., Flory, C.M., Miller, B.F., Evans, V.M., and Warren, J.S. 1996. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am. J. Pathol. 149: 953-961.
25. Leavitt, R.Y., Fauci, A.S., Bloch, D.A., Michel, B.A., Hunder, G.G., Arend, W.P., Calabrese, L.H., Fries, J.F., Lie, J.T., Lightfoot, R.W., Jr., et al. 1990. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 33: 1101-1107.
26. Lightfoot, R.W., Jr., Michel, B.A., Bloch, D.A., Hunder, G.G., Zvaifler, N.J., McShane, D.J., Arend, W.P., Calabrese, L.H., Leavitt, R.Y., Lie, J.T., et al. 1990. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 33: 1088-1093.
27. Masi, A.T., Hunder, G.G., Lie, J.T., Michel, B.A., Bloch, D.A., Arend, W.P., Calabrese, L.H., Edworthy, S.M., Fauci, A.S., Leavitt, R.Y., et al. 1990. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 33: 1094-1100.
28. Matsui, T., Kurokawa, M., Kobata, T., Oki, S., Azuma, M., Tohma, S., Inoue, T., Yamamoto, K., Nishioka, K., and Kato, T. 1999. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. J. Immunol. 162: 4328-4335.
29. Mills, J.A., Michel, B.A., Bloch, D.A., Calabrese, L.H., Hunder, G.G., Arend, W.P., Edworthy, S.M., Fauci, A.S., Leavitt, R.Y., Lie, J.T., et al. 1990. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum. 33: 1114-1121.
30. Mitsumoto, A., Takanezawa, Y., Okawa, K., Iwamatsu, A., and Nakagawa, Y. 2001. Variants of peroxiredoxins expression in response to hydroperoxide stress. Free Radic. Biol. Med. 30: 625-635.
31. Okado-Matsumoto, A., Matsumoto, A., Fujii, J., and Taniguchi, N. 2000. Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J. Biochem. (Tokyo) 127: 493-501.
32. Orth, T., Kellner, R., Diekmann, O., Faust, J., Meyer zum Buschenfelde, K.H., and Mayet, W.J. 1998. Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin. Exp. Immunol. 112: 507-515.
33. Peshenko, I.V., and Shichi, H. 2001. Oxidation of active center cysteine of bovine 1-Cys peroxiredoxin to the cysteine sulfenic acid form by peroxide and peroxynitrite. Free Radic. Biol. Med. 31: 292-303.
34. Poole, L.B., and Ellis, H.R. 1996. Flavin-dependent alkyl hydroperoxide reductase from Salmonella typhimurium. 1. Purification and enzymatic activities of overexpressed AhpF and AhpC proteins. Biochemistry 35: 56-64.
35. Sambo, P., Baroni, S.S., Luchetti, M., Paroncini, P., Dusi, S., Orlandini, G., and Gabrielli, A. 2001. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum. 44: 2653-2664.
36. Swets, B.P., Brouwer, D.A., and Tervaert, J.W. 2001. Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL. Clin. Exp. Immunol. 124: 163-167.
37. Tan, E.M., Cohen, A.S., Fries, I.F., Masi, A.T., McShane, D.J., Rothfield, N.F., Schaller, J.G., Talal, N., and Winchester, R.J. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
38. Thiel, S., Vorup-Jensen, T., Stover, C.M., Schwaeble, W., Laursen, S.B., Poulsen, K., Willis, A.C., Eggleton, P., Hansen, S., Holmskov, U., Reid, K.B., and Jensenius, J.C. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386: 506-510.
39. Turner, M.W. 1996. The lectin pathway of complement activation. Res. Immunol. 147: 110-115.
40. Vasishta, A. 2002. Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies. Am. Clin. Lab. 21: 34-36.
41. Vittecoq, O., Salle, V., Jouen-Beades, F., Krzanowska, K., Menard, J.F., Gayet, A., Fardellone, P., Tauveron, P., Le Loet, X., and Iron, F. 2001. Autoantibodies to the 27 C-terminal amino acids of calpastatin are detected in a restricted set of connective tissue diseases and may be useful for diagnosis of rheumatoid arthritis in community cases of very early arthritis. Rheumatology (Oxford) 40: 1126-1134.
42. Wood, Z.A., Schroder, E., Robin Harris, J., and Poole, L.B. 2003. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28: 32-40.
43. Xiang, Y., Sekine, T., Nakamura, H., Imajoh-Ohmi, S., Fukuda, H., Nishioka, K., and Kato, T. 2004. Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis Rheum. 50: 1511-1521.